Oppenheimer & CO Inc Illumina, Inc. Transaction History
Oppenheimer & CO Inc
- $7.23 Billion
- Q2 2025
A detailed history of Oppenheimer & CO Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 42,249 shares of ILMN stock, worth $4.11 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
42,249
Previous 42,463
0.5%
Holding current value
$4.11 Million
Previous $3.37 Million
19.62%
% of portfolio
0.06%
Previous 0.05%
Shares
32 transactions
Others Institutions Holding ILMN
# of Institutions
876Shares Held
152MCall Options Held
1.67MPut Options Held
1.36M-
Black Rock Inc. New York, NY18.1MShares$1.76 Billion0.04% of portfolio
-
Capital World Investors Los Angeles, CA16.6MShares$1.62 Billion0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$1.48 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.85MShares$570 Million0.02% of portfolio
-
Sessa Capital Im, L.P. New York, NY4.72MShares$460 Million13.63% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $15.3B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....